Impact of Subgingival Instrumentation on Masticatory Performance and Psychological Distress
1 other identifier
interventional
92
1 country
1
Brief Summary
Patients of Stage III and Stage IV Periodontitis will be assessed for masticatory dysfunction and psychological distress. Subgingival Instrumentation will be done for treating periodontitis. Patients will be re-evaluated after 2 and 3 months in order to assess any change in masticatory dysfunction and psychological distress by improved periodontal health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 10, 2023
CompletedFirst Posted
Study publicly available on registry
September 6, 2023
CompletedStudy Start
First participant enrolled
September 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2024
CompletedMay 17, 2024
May 1, 2024
1 year
August 10, 2023
May 16, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
Masticatory performance
Objective Masticatory Performance will be evaluated using colour mixing ability of a chewing gum, through optoelectronic analysis using a software. Subjective masticatory performance will be calculated using The Quality of Masticatory Function questionnaire which consists of 29 questions related to frequency and difficulty of chewing different types of foods in the previous 2 weeks.
Baseline, 2 months, 3 months
Hospital Anxiety and Depression Scale 14
The HADS constitutes 14 items grouped into two subscales: "anxiety subscale" (HADS-A), as well as "depression subscale" (HADS-D). The responses to the items are graded from 0 (absence of manifestations) to 3 (severe manifestations). Scores are summated to yield the total score, and greater scores indicate more severe anxiety, as well as depressive indications. DASS-21 measures emotional distress in three subcategories of depression (e.g., loss of self-esteem/incentives and depressed mood), anxiety (e.g., fear and anticipation of negative events), and stress (e.g., persistent state of over arousal and low frustration tolerance). It is a self-reporting questionnaire with 21 items (seven items for each category) based on a four-point rating scale. Higher score represents more severe emotional distress.
Baseline, 2 months, 3 months
Depression Anxiety and Stress Scale 21
DASS-21 measures emotional distress in three subcategories of depression (e.g., loss of self-esteem/incentives and depressed mood), anxiety (e.g., fear and anticipation of negative events), and stress (e.g., persistent state of over arousal and low frustration tolerance). It is a self-reporting questionnaire with 21 items (seven items for each category) based on a four-point rating scale. Higher score represents more severe emotional distress.
Baseline, 2 months, 3 months
Secondary Outcomes (2)
Pocket Probing Depth
Baseline, 2 months, 3 months
Clinical attachment level
Baseline, 2 months, 3 months
Study Arms (1)
Stage III and Stage IV Periodontitis
OTHERSubgingival Instrumentation will be performed in patients with Stage III and Stage IV periodontitis.
Interventions
Subgingival Instrumentation will be performed in patients with Stage III and IV periodontitis.
Eligibility Criteria
You may qualify if:
- Adult patients with age group 30-50 years diagnosed with stage III/IV generalized periodontitis.
- Presence of minimum 20 teeth (Eichner group A1, A2, A3) excluding third molars.
You may not qualify if:
- Systemic diseases that may affect periodontal disease progression or outcome of treatment (diabetes, autoimmune diseases)
- Systemic diseases that may affect masticatory ability of the patient (sarcopenia, TMJ disorders, Xerostomia, Acute Pulpitis)
- Periodontal treatment within the 6 months
- Patients wearing orthodontic appliances
- Any diagnosed psychiatric disorder
- Antibiotic use within the previous 3 months
- Steroid, immunosuppressive and psychiatric drug use
- Pregnant and lactating women
- History of menopause
- Smoking or substance abuse
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Post Graduate Institute of Dental Sciences
Rohtak, Haryana, 124001, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Janvi Janvi, BDS
PGIDS Rohtak
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 10, 2023
First Posted
September 6, 2023
Study Start
September 15, 2023
Primary Completion
September 15, 2024
Study Completion
October 15, 2024
Last Updated
May 17, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share